Disappointing End For MolMed’s Zalmoxis Cell Therapy In EU

Real World Data Played A Key Role In The Drug’s Initial Approval

 
• By Vibha Sharma
  
Clinical trial
Zalmoxis Failed To Meet Its Primary Endpoint • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography